FDA approves new version of diabetes drug Mounjaro for weight loss ...Middle East

By JONEL ALECCIA AP Health Writer A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday. The U.S. Food and Drug Administration approved Eli Lilly’s Zepbound, or tirzepatide. The drug helped dieters lose about a quarter of their body weight, or 60 pounds (27 kilograms), in a recent study. Zepbound is the latest diabetes drug approved for weight loss, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. The F DA approved Lilly’s drug for people who are considered obese, with a body mass index of 30 or higher, or those who are overweight with a related health condition, like high

Hence then, the article about fda approves new version of diabetes drug mounjaro for weight loss was published today ( Wednesday 08/11/2023 - 09:32 PM ) and is available on News channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves new version of diabetes drug Mounjaro for weight loss )

Also on site :

• Kyle Busch’s Car Unloaded at North Carolina Racetrack After Shocking Death, on Video
• Inside the epicenter of the Ebola outbreak in DRC as the virus spreads
• White House shooter Naseer Best, 21, who identified himself as Jesus Christ shot dead